2006
DOI: 10.1590/s1516-93322006000300003
|View full text |Cite
|
Sign up to set email alerts
|

Liberação específica de fármacos para administração no cólon por via oral. I - O cólon como local de liberação de fármacos

Abstract: A liberação específica de fármacos no cólon tem atraído a atenção de investigadores interessados no tratamento de patologias locais e no

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 53 publications
0
4
0
2
Order By: Relevance
“…The oral administration route is the most recommended in developing drugs for tropical diseases, because it is considered easy for patients to adhere to treatment; therefore, it is necessary for the drugs to have good oral bioavailability they can be linked to good solubility and essential permeability to predict the ability of compounds to reach their target at established concentrations [ 65 , 66 ].…”
Section: Resultsmentioning
confidence: 99%
“…The oral administration route is the most recommended in developing drugs for tropical diseases, because it is considered easy for patients to adhere to treatment; therefore, it is necessary for the drugs to have good oral bioavailability they can be linked to good solubility and essential permeability to predict the ability of compounds to reach their target at established concentrations [ 65 , 66 ].…”
Section: Resultsmentioning
confidence: 99%
“…To obtain maximum absorption of the drug in the colon, there should be minimal or null absorption through the gastric mucosa and small intestine and, to this effect, the resistance time in these regions should be considered. Transit of the pharmaceutical form through the stomach ranges from minutes to 2 hours (acidic pH) and, through the small intestine, the transit time is approximately 3-4 hours (Freire et al, 2006;Sanghi and Tiwle, 2016).…”
Section: In Vitro Dissolution Profilementioning
confidence: 99%
“…8B) showed distinct amorphous halo and characteristic peaks indicating the semi-crystalline nature of this polymers. The peaks around 171, 231 and 251 (2θ) are characteristic of the B-type polymorphous, while the peak in 19.81 is typical of V polymorph indicating a well-organized crystalline structure of amylose-lipid complexes present in the starch granules (Carbinatto et al, 2012;Freire et al, 2006;Shamai et al, 2003;Soares et al, 2013).…”
Section: X-ray Diffraction (Xrd) Analysismentioning
confidence: 99%